FEATURED ARTICLES
-
![Clinical Supply Packaging For Biological Products eBook]( "Clinical Supply Packaging For Biological Products")
Clinical Supply Packaging For Biological ProductsThe advantages of biologics over their small molecule predecessors are not without their costs. This e-book addresses the challenges in managing the biologic supply chain.
LIFE SCIENCE WEBINARS
-
![Patheon]( "Benefits Of 5KL Bioreactor When Outsourcing Late-Phase Biologics Drug Substance Manufacturing")
Benefits Of 5KL Bioreactor When Outsourcing Late-Phase Biologics Drug Substance ManufacturingWatch this webinar today to discover how Thermo Fisher Scientific is addressing and overcoming two critical, current challenges in upstream bioprocessing.
-
![Egnyte]( "IND Best Practices: 5 Tips For A Successful Filing")
IND Best Practices: 5 Tips For A Successful FilingThere are many steps that need to be performed in order to assemble an Investigational New Drug (IND) Application. Whether it be consulting with the FDA, using a GxP compliant collaboration platform, or finding a partner, this process is often complex. Despite the numerous steps, it does not have to be an insurmountable goal. This webinar reviews 5 key best practices for assembling your IND and identifies specific tips that you can integrate into your workflow today.
-
![IDBS-polar-webinar]( "Something Big Is About To Take Biopharma Development Into The Digital Age")
Something Big Is About To Take Biopharma Development Into The Digital AgeIDBS are announcing the world’s first Biopharma Lifecycle Management (BPLM) system – a cloud-based platform that smooths the bumps of biopharmaceutical development – easing the curation of the data you need to accelerate time to market.
-
![Achieving Faster Formulation Of Solid Oral Dosage Forms For First-In-Human Supplies Using Drug In Capsule Approach]( "Biologics Drug Product: Formulation, Tech Transfer, Delivery Strategies")
Biologics Drug Product: Formulation, Tech Transfer, Delivery StrategiesThis webinar covers the key considerations for formulation screening of therapeutic proteins with a focus on maintaining protein stability and avoiding aggregation.
